CordenPharma unloads amino acid portfolio; Russia postpones enforcing GMP on domestic industry;

> India's Drug Controller General G.N. Singh says he was not accurately quoted about statements he made regarding the effects on Indian drugmakers if he held them to U.S. FDA standards. Notice

> The European Parliament wants to strengthen its powers to seize counterfeit products and other assets in criminal cases. Report

> Swiss API maker CordenPharma has transferred its entire amino acid building blocks product portfolio to CU Chemie Uetikon GmbH, based in Lahr, Germany. Release

> U.S.-based Cellceutix has picked India's Dr. Reddy's Laboratories to formulate its antibiotic product because of Dr. Reddy's extensive knowledge in manufacturing and formulating anti-infective therapeutics. Report

> New York-based Tauriga Sciences says it has a memorandum of understanding to buy a leading California manufacturer of topical medicinal cannabis products. Report

> Almac has added a new blister pack line at its plant in Audubon, PA. Release

And Finally... Russia has decided not to enforce new cGMP requirements on its domestic drugmakers until 2016 instead of this year. Story